Kramer Kelly A. at Gilead Sciences, Inc. (GILD) Sells 4,700 Shares
Kramer Kelly A., of Gilead Sciences, Inc. (NASDAQ:GILD), sold 4,700 shares of company stock on November 12, 2026, according to a Form 4 filing with the Securities and Exchange…
Gilead Sciences, Inc. (NASDAQ:GILD) · insider sell
Insider
Kramer Kelly A.
Transaction
insider sell
Shares
4,700
Price per share
$170.49
Total value
$801.3K
Shares owned after
1,539
At a glance
Key takeaways
01Kramer Kelly A. sold 4,700 shares of Gilead Sciences on November 12, 2026 at $170.49 per share, generating $801.3K in proceeds.
02The insider still holds 1,539 shares following the transaction and sold over 20,000 shares total on the same day.
03Gilead Sciences stock trades at $170.26 with a market capitalization of $152.9B as of the transaction date.
04Single insider sales alone do not indicate bearish sentiment; executives commonly sell for tax planning, diversification, or liquidity needs.
05Patterns of insider activity tracked over time alongside other metrics provide more meaningful signals than isolated transactions.
Transaction Details
Kramer Kelly A., of Gilead Sciences, Inc. (NASDAQ:GILD), sold 4,700 shares of company stock on November 12, 2026, according to a Form 4 filing with the Securities and Exchange Commission.
The shares were sold at an average price of $170.49 per share, for a total transaction value of $801.3K. Following this transaction, Kramer Kelly A. still owns 1,539 shares of Gilead Sciences, Inc. stock.
About Gilead Sciences, Inc.
Gilead Sciences, Inc.'s stock currently trades at $170.26, giving the company a market capitalization of $152.9B.
Insider sales are common and don't necessarily indicate a bearish outlook. Executives regularly sell shares for tax planning, diversification, or personal liquidity. The key factors to watch are the size of the sale relative to the insider's total holdings, whether multiple insiders are selling simultaneously, and whether the trades occur near earnings announcements or other catalysts.
This $801K transaction is a notable data point for investors tracking insider sentiment at Gilead Sciences, Inc. While any single trade should be viewed in context, patterns of insider activity over time can provide valuable directional signals.
Insider transaction data is reported to the SEC via Form 4 filings, typically within two business days of the trade. Investors can track insider activity alongside other metrics — such as institutional flows, short interest, and technical indicators — to build a more complete picture of market sentiment around Gilead Sciences, Inc.
Recent Insider Transactions at Gilead Sciences, Inc.
What does insider insider_sell mean for Gilead Sciences, Inc. stock?
Insider insider_sells at Gilead Sciences, Inc. (NASDAQ:GILD) are reported to the SEC via Form 4 filings. While a single transaction doesn't predict future stock performance, patterns of insider buying can signal management confidence.